Copyright
©The Author(s) 2022.
World J Cardiol. Jan 26, 2022; 14(1): 29-39
Published online Jan 26, 2022. doi: 10.4330/wjc.v14.i1.29
Published online Jan 26, 2022. doi: 10.4330/wjc.v14.i1.29
Term | Definition |
Allele | One of several alternative versions of a particular gene |
Heterozygote | An individual who has different alleles at a particular gene locus on homologous chromosomes (carrier of a single copy of the mutation) |
Mutation | Any alteration in the inherited nucleic acid sequence of the genotype of an organism; a mutation considered in the context of a genetic disease usually refers to an alteration that causes a Mendelian disease |
Penetrance | Proportion of individuals carrying a mutation who also express a cardiomyopathy phenotype |
Genome sequencing | Sequencing of entire genome (coding and non-coding regions) |
Exome sequencing | Sequencing of the coding regions (exons) |
Proband or index case | Index case in the family, usually the one with the most severe phonotype |
Variant | A change in the DNA sequence which may or may not be disease-causing |
Pathogenicity | Process of determining whether a variant is causative or not |
- Citation: Vogiatzi G, Lazaros G, Oikonomou E, Lazarou E, Vavuranakis E, Tousoulis D. Role of genetic testing in cardiomyopathies: Α primer for cardiologists. World J Cardiol 2022; 14(1): 29-39
- URL: https://www.wjgnet.com/1949-8462/full/v14/i1/29.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i1.29